what is glp 1 prescription GLP-1 Weight Loss Options New Daily GLP-1 Weight Loss

Shah et al., 2022

A large real world evidence demonstrated that when comparing several GLP-1 receptor agonists versus DPP-4 inhibitors treatments in patients with a baseline cardiovascular risk, the incidence of adverse events was much lower for the former [8]

For the inclusion criteria, the authors collected all the published papers which were written in English language only and they took published papers from (2002) to (2023) years only, and For exclusion criteria, they excluded non-English articles, letters, editorials, conference abstracts, practice guidelines, news articles, and conference reports

10.1016/j.rbp.2011.12.001 Braz J Psychiatry

[6] Treating cagrilintide and tirzepatide as the same kind of drug misreads the biology: they touch appetite from different directions, and neither pathway makes one a substitute for the other

doi: 10.3389/fnagi.2020.00150 74 ZhaoN.LiuC